Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent developments in immunotherapy of acute myeloid leukemia
Felix S. Lichtenegger, Christina Krupka, Sascha Haubner, et al.
Journal of Hematology & Oncology (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 128

Showing 1-25 of 128 citing articles:

Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity
Peter van Galen, Volker Hovestadt, Marc H. Wadsworth, et al.
Cell (2019) Vol. 176, Iss. 6, pp. 1265-1281.e24
Open Access | Times Cited: 878
Immunosenescence: a key player in cancer development
Jingyao Lian, Ying Yue, Weina Yu, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 333
Molecular biomarkers in acute myeloid leukemia
Jeanette Prada-Arismendy, Johanna C. Arroyave-Ospina, Sarah Röthlisberger
Blood Reviews (2016) Vol. 31, Iss. 1, pp. 63-76
Closed Access | Times Cited: 277
T cell senescence and CAR-T cell exhaustion in hematological malignancies
Dimitri Kasakovski, Ling Xu, Yangqiu Li
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 232
Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia
Tobias Herold, Maja Rothenberg‐Thurley, Victoria V. Grunwald, et al.
Leukemia (2020) Vol. 34, Iss. 12, pp. 3161-3172
Open Access | Times Cited: 165
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Ahmet Yılmaz, Hanwei Cui, Michael A. Caligiuri, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 148
Research progress on dendritic cell vaccines in cancer immunotherapy
Jifeng Yu, Haowei Sun, Weijie Cao, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 119
CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia
Jinghua Wang, Siyu Chen, Wei Xiao, et al.
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 161
FLT3 inhibitors in acute myeloid leukemia
Mei‐Hwan Wu, Chuntuan Li, Xiongpeng Zhu
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 144
Advances in targeted therapy for acute myeloid leukaemia
Sabine Käyser, Mark J. Levis
British Journal of Haematology (2017) Vol. 180, Iss. 4, pp. 484-500
Open Access | Times Cited: 116
A Novel Anti-LILRB4 CAR-T Cell for the Treatment of Monocytic AML
Samuel John, Heyu Chen, Mi Deng, et al.
Molecular Therapy (2018) Vol. 26, Iss. 10, pp. 2487-2495
Open Access | Times Cited: 108
Characterization of Immune Dysfunction and Identification of Prognostic Immune-Related Risk Factors in Acute Myeloid Leukemia
Lu Tang, Jianghua Wu, Cheng-Gong Li, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 7, pp. 1763-1772
Open Access | Times Cited: 101
Compound CAR T-cells as a double-pronged approach for treating acute myeloid leukemia
Jessica C. Petrov, M. Wada, Kevin G. Pinz, et al.
Leukemia (2018) Vol. 32, Iss. 6, pp. 1317-1326
Open Access | Times Cited: 100
Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells
Ying Wang, Yingxi Xu, Saisai Li, et al.
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 97
Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia
Monika Herrmann, Christina Krupka, Katrin Deiser, et al.
Blood (2018) Vol. 132, Iss. 23, pp. 2484-2494
Open Access | Times Cited: 92
Natural killer cell-based immunotherapy for acute myeloid leukemia
Jing Xu, Ting Niu
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 90
Immunotherapy in Acute Myeloid Leukemia: Where We Stand
Alessandro Isidori, Claudio Cerchione, Naval Daver, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 85
Carrier-Free Nanoplatform via Evoking Pyroptosis and Immune Response against Breast Cancer
Lei Li, Hailong Tian, Zhe Zhang, et al.
ACS Applied Materials & Interfaces (2022) Vol. 15, Iss. 1, pp. 452-468
Closed Access | Times Cited: 51
Targeted Therapy Development in Acute Myeloid Leukemia
Tulasigeri M. Totiger, Anirban Ghoshal, Jenna Zabroski, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 641-641
Open Access | Times Cited: 27
Novel Approaches to Acute Myeloid Leukemia Immunotherapy
Ofrat Beyar‐Katz, Saar Gill
Clinical Cancer Research (2018) Vol. 24, Iss. 22, pp. 5502-5515
Closed Access | Times Cited: 60
Successful Anti-CLL1 CAR T-Cell Therapy in Secondary Acute Myeloid Leukemia
Hui Zhang, Wenting Gan, Wen-Ge Hao, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 51
Biomarkers as targets for CAR-T/NK cell therapy in AML
Ruonan Shao, Zijian Li, Hong-Lei Xin, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 22
An Anti–CLL-1 Antibody–Drug Conjugate for the Treatment of Acute Myeloid Leukemia
Bing Zheng, Shang‐Fan Yu, Geoffrey Del Rosario, et al.
Clinical Cancer Research (2018) Vol. 25, Iss. 4, pp. 1358-1368
Open Access | Times Cited: 59
Acute myeloid leukemia chimeric antigen receptor T-cell immunotherapy: how far up the road have we traveled?
Sarah K. Tasian
Therapeutic Advances in Hematology (2018) Vol. 9, Iss. 6, pp. 135-148
Open Access | Times Cited: 55
Bone marrow CD8 T cells express high frequency of PD-1 and exhibit reduced anti-leukemia response in newly diagnosed AML patients
Bei Jia, Liru Wang, David F. Claxton, et al.
Blood Cancer Journal (2018) Vol. 8, Iss. 3
Open Access | Times Cited: 53
Page 1 - Next Page

Scroll to top